ONCOLYTICS BIOTECH INC. Other Comprehensive Income Net Of Tax Exchange Differences On Translation
ONCOLYTICS BIOTECH INC. (ONCY) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of CAD 417.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2025-03-07
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month as first filed |
|---|---|---|
| 2024-12-31 | 417.00K CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | -118.00K CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | 274.00K CAD 20-F · filed 2025-03-07 | |
| 2021-12-31 | -12.00K CAD 20-F · filed 2024-03-12 | -12.49K CAD 20-F · filed 2022-03-03 |
| 2020-12-31 | -64.00K CAD 20-F · filed 2023-03-03 | -63.88K CAD 20-F · filed 2021-03-05 |
| 2019-12-31 | -143.40K CAD 20-F · filed 2022-03-03 | |
| 2018-12-31 | 233.77K CAD 20-F · filed 2021-03-05 | |
| 2017-12-31 | -180.33K CAD 20-F · filed 2020-03-06 | |
| 2016-12-31 | -206.92K CAD 20-F · filed 2019-03-15 | |
| 2015-12-31 | 480.94K CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |